Yongyi Zeng
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Neoantigen Vaccine Plus Capecitabine as Adjuvant Therapy for Intrahepatic Cholangiocarcinoma After Radical Resection (NCT06406816) | Yongyi Zeng | 2024-05-06 |
| Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT (NCT06349317) | Yongyi Zeng | 2024-04-22 |
Track Yongyi Zeng automatically
Every clearance here is in the API, with alerts when new ones post.